Herpes Simplex Patient Population, Treatment Algorithm, Medical Practices And Epidemiology Forecast To 2030

 Breaking News
  • No posts were found

Herpes Simplex Patient Population, Treatment Algorithm, Medical Practices And Epidemiology Forecast To 2030

August 13
09:26 2020
Herpes Simplex Patient Population, Treatment Algorithm, Medical Practices And Epidemiology Forecast To 2030

Delveinsight Business Research
DelveInsight’s ‘Herpes Simplex Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Herpes Simplex epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

The Herpes Simplex Virus, also known as HSV, is an infection which leads to small, painful, fluid-filled blisters on the skin, mouth, lips, eyes or genitals. This infection is categorized into two types: Herpes Simplex Virus Type-1 (HSV-1) and Herpes Simplex Virus Type-2 (HSV-2). 

HSV-1 (Oral Herpes) is a highly contagious and common infection that is mainly transmitted by oral contact in or around the mouth, causing cold sores/Herpes Labialis as well as Genital Herpes in some cases. On the other hand, HSV-2 (Genital Herpes) is transmitted sexually (genital-to-genital, oral-to-genital, or genital-to-oral) and perinatally (mother to child). Both HSV-1 and HSV-2 infections are lifelong. It is more common among the women than in men.

 

Get FREE sample copy at: 

https://www.delveinsight.com/sample-request/herpes-simplex-epidemiology-forecast

 

Herpes-Simplex-Epidemiology-Forecast

The DelveInsight Herpes Simplex epidemiology report gives a thorough understanding of the Herpes Simplex by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for  Herpes Simplex in the US, Europe, and Japan. The report covers the detailed information of the  Herpes Simplex epidemiology scenario in seven major countries (US, EU5, and Japan).

 

Key Highlights Of The Report

As per the Centers for Disease Control and Prevention, approximately, 776,000 people in the United States develop new Herpes Infections, while one out of every six people aged 14 to 49 years have Genital herpes.

 As per American Academy of Pediatrics, Most people are first exposed to HSV between 1 and 5 years of age

 

Herpes Simplex Epidemiology

  • Delveinsight’s Herpes Simplex epidemiology division provides insights about historical and current patient pool and forecasted trends for every seven major countries. 

  • The Herpes Simplex epidemiology data are studied through all possible divisions to give a better understanding of the Disease scenario in 7MM. 

  • The Herpes Simplex epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. 

  • It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

 

Scope of the Report

  • The report provides insight into the historical and forecasted patient pool of Herpes Simplex in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.

  • The report assesses the disease risk and burden and highlights the unmet needs of  Herpes Simplex.

  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.

  • The Herpes Simplex report provides a detailed overview explaining Herpes Simplex causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns.

  • The Herpes Simplex Epidemiology Report and Model provide an overview of the risk factors and global trends of  Herpes Simplex in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan).

  • The report provides the segmentation of the  Herpes Simplex epidemiology. 

 

Key Benefit of Herpes Simplex Epidemiology Report 

The Herpes Simplex Epidemiology report will allow the user to –

  • Develop business strategies by understanding the trends shaping and driving the global Herpes Simplex market

  • Quantify patient populations in the global Herpes Simplex market to improve product design, pricing, and launch plans

  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Herpes Simplex therapeutics in each of the markets covered

  • Understand the magnitude of Herpes Simplex population by its epidemiology

  • The Herpes Simplex Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

 

Table of Contents

  1. Key Insights 

  2. Executive Summary of Herpes Simplex

  3.  Herpes Simplex Disease Background and Overview

  4.  Herpes Simplex Patient Journey

  5.  Herpes Simplex Epidemiology and Patient Population

  6.  Herpes Simplex Treatment Algorithm, Current Treatment, and Medical Practices

  7. KOL Views on  Herpes Simplex 

  8.  Herpes Simplex Unmet Needs

  9. Appendix

  10. DelveInsight Capabilities

  11. Disclaimer

*The table of contents is not exhaustive; will be provided in the final report

 

Related Reports

Herpes Simplex Market Insight, Epidemiology and Market Forecast -2030

DelveInsight’s “Herpes Simplex – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Herpes Simplex, historical and forecasted epidemiology as well as the Herpes Simplex market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Herpes Simplex Pipeline Insights, 2020

Herpes Simplex Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Herpes Simplex market.

 

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

Related Articles

Categories